PHARM - Pharming reports second quarter and first half 2026 financial results and revises year-end guidance; strong Joenja momentum and near
PHARM - Pharming reports second quarter and first half 2026 financial results and revises year-end guidance; strong Joenja momentum and near-term clinical readouts to support broader therapeutic use - Click For Release
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.